Evidence map›Paper›PMID 31440126›Full record

ArticleFrontiers in neuroscience2019

Safety Aspects, Tolerability and Modeling of Retinofugal Alternating Current Stimulation.

Linus Haberbosch, Abhishek Datta, Chris Thomas, Andreas Jooß, Arvid Köhn, Maria Rönnefarth, Michael Scholz, Stephan A Brandt, Sein Schmidt

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. The interplay between pulse width and activation depth in TENS: a computational study.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Evaluating Current Density Modeling of Non-Invasive Eye and Brain Electrical Stimulation Using Phosphene Thresholds.IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Linus HaberboschDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Abhishek DattaResearch and Development, Soterix Medical, New York, NY, United States.
Chris ThomasResearch and Development, Soterix Medical, New York, NY, United States.
Andreas JooßDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Arvid KöhnDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Maria RönnefarthDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Michael ScholzNeural Information Processing Group, Technical University of Berlin, Berlin, Germany.
Stephan A BrandtDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sein SchmidtDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile alternating current stimulation (ACS) is gaining relevance as a tool in research and approaching clinical applications, its mechanisms of action remain unclear. A review by Schutter and colleagues argues for a retinal origin of transcranial ACS' neuromodulatory effects. Interestingly, there is an alternative application form of ACS specifically targeting α-oscillations in the visual cortex via periorbital electrodes (retinofugal alternating current stimulation, rACS). To further compare these two methods and investigate retinal effects of ACS, we first aim to establish the safety and tolerability of rACS.

objectiveThe goal of our research was to evaluate the safety of rACS via finite-element modeling, theoretical safety limits and subjective report.

methods20 healthy subjects were stimulated with rACS as well as photic stimulation and reported adverse events following stimulation. We analyzed stimulation parameters at electrode level as well as distributed metric estimates from an ultra-high spatial resolution magnetic resonance imaging (MRI)-derived finite element human head model and compared them to existing safety limits.

resultsTopographical modeling revealed the highest current densities in the anterior visual pathway, particularly retina and optic nerve. Stimulation parameters and finite element modeling estimates of rACS were found to be well below existing safety limits. No serious adverse events occurred.

conclusionOur findings are in line with existing safety guidelines for retinal and neural damage and establish the tolerability and feasibility of rACS. In comparison to tACS, retinofugal stimulation of the visual cortex provides an anatomically circumscribed model to systematically study the mechanisms of action of ACS.

Indexed as

adverse eventselectrical stimulationfeasibilityfinite element modelingretinofugal alternating current stimulationsafetytolerability

Identifiers

PMID31440126
PMCPMC6692662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.